Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Design Therapeutics (DSGN) over the last 5 years, with Dec 2024 value amounting to $56.6 million.

  • Design Therapeutics' Shares Outstanding (Weighted Average) rose 3.43% to $55.7 million in Q4 2021 from the same period last year, while for Sep 2021 it was $55.6 million, marking a year-over-year change of. This contributed to the annual value of $56.6 million for FY2024, which is 1.11% up from last year.
  • As of FY2024, Design Therapeutics' Shares Outstanding (Weighted Average) stood at $56.6 million, which was up 1.11% from $56.0 million recorded in FY2023.
  • Over the past 5 years, Design Therapeutics' Shares Outstanding (Weighted Average) peaked at $56.6 million during FY2024, and registered a low of $53.8 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $56.2 million, with a median of $56.0 million in 2023.
  • Data for Design Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 3.43% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Design Therapeutics' Shares Outstanding (Weighted Average) stood at $53.8 million in 2020, then increased by 3.43% to $55.7 million in 2021, then grew by 0.44% to $55.9 million in 2022, then climbed by 0.16% to $56.0 million in 2023, then grew by 1.11% to $56.6 million in 2024.